Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 934 entries
Sorted by: Best Match Show Resources per page
Diagnosis and Treatment of Childhood Migraine.

Current treatment options in neurology

Merison K, Jacobs H.
PMID: 27704257
Curr Treat Options Neurol. 2016 Nov;18(11):48. doi: 10.1007/s11940-016-0431-4.

OPINION STATEMENT: While the diagnosis of migraine in children is generally straightforward, treatment can seem complex with a number of medication choices, many of which are used "off label." Patients with intermittent migraines can often be managed with ibuprofen...

Cite
Merison K, Jacobs H. Diagnosis and Treatment of Childhood Migraine. Curr Treat Options Neurol. 2016;18(11):48doi: 10.1007/s11940-016-0431-4.
Merison, K., & Jacobs, H. (2016). Diagnosis and Treatment of Childhood Migraine. Current treatment options in neurology, 18(11), 48. https://doi.org/10.1007/s11940-016-0431-4
Merison, Kelsey, and Jacobs, Howard. "Diagnosis and Treatment of Childhood Migraine." Current treatment options in neurology vol. 18,11 (2016): 48. doi: https://doi.org/10.1007/s11940-016-0431-4
Merison K, Jacobs H. Diagnosis and Treatment of Childhood Migraine. Curr Treat Options Neurol. 2016 Nov;18(11):48. doi: 10.1007/s11940-016-0431-4. PMID: 27704257.
Copy Download .nbib Format: NLM
Potential for specific dihydropyridine calcium channel blockers to have a positive impact on cognitive function in humans: a systematic review.

Therapeutic advances in chronic disease

Peters J, Booth A, Peters R.
PMID: 26137206
Ther Adv Chronic Dis. 2015 Jul;6(4):160-9. doi: 10.1177/2040622315582353.

BACKGROUND: There is some evidence to suggest a possible association between calcium channel blocker (CCB) use and a lower decline in cognitive function compared with use of other hypertensive treatments. In particular, there is an emerging interest in the...

Cite
Peters J, Booth A, Peters R. Potential for specific dihydropyridine calcium channel blockers to have a positive impact on cognitive function in humans: a systematic review. Ther Adv Chronic Dis. 2015;6(4):160-9doi: 10.1177/2040622315582353.
Peters, J., Booth, A., & Peters, R. (2015). Potential for specific dihydropyridine calcium channel blockers to have a positive impact on cognitive function in humans: a systematic review. Therapeutic advances in chronic disease, 6(4), 160-9. https://doi.org/10.1177/2040622315582353
Peters, Jean, et al. "Potential for specific dihydropyridine calcium channel blockers to have a positive impact on cognitive function in humans: a systematic review." Therapeutic advances in chronic disease vol. 6,4 (2015): 160-9. doi: https://doi.org/10.1177/2040622315582353
Peters J, Booth A, Peters R. Potential for specific dihydropyridine calcium channel blockers to have a positive impact on cognitive function in humans: a systematic review. Ther Adv Chronic Dis. 2015 Jul;6(4):160-9. doi: 10.1177/2040622315582353. PMID: 26137206; PMCID: PMC4480546.
Copy Download .nbib Format: NLM
Hypertensive patients with and without kidney disease: assessment of risk factors.

Revista da Escola de Enfermagem da U S P

Pinho NA, Oliveira Rde C, Pierin AM.
PMID: 26761699
Rev Esc Enferm USP. 2015 Feb;49:101-8. doi: 10.1590/S0080-623420150000700015.

Objective To compare hypertensive patients with and without chronic kidney disease and identify factors associated with their clinical condition and antihypertensive treatment. Method This was a cross-sectional study conducted with patients hospitalized in a general medical ward at a...

Cite
Pinho NA, Oliveira Rde C, Pierin AM. Hipertensos com e sem doença renal: avaliação de fatores de risco. Hypertensive patients with and without kidney disease: assessment of risk factors. Rev Esc Enferm USP. 2015;49:101-8doi: 10.1590/S0080-623420150000700015.
Pinho, N. A., Oliveira, R. d. e. . C., & Pierin, A. M. (2015). Hipertensos com e sem doença renal: avaliação de fatores de risco. Hypertensive patients with and without kidney disease: assessment of risk factors. Revista da Escola de Enfermagem da U S P, 49101-8. https://doi.org/10.1590/S0080-623420150000700015
Pinho, Natália Alencar de, et al. "Hipertensos com e sem doença renal: avaliação de fatores de risco." Hypertensive patients with and without kidney disease: assessment of risk factors. Revista da Escola de Enfermagem da U S P vol. 49 (2015): 101-8. doi: https://doi.org/10.1590/S0080-623420150000700015
Pinho NA, Oliveira Rde C, Pierin AM. Hipertensos com e sem doença renal: avaliação de fatores de risco. Hypertensive patients with and without kidney disease: assessment of risk factors. Rev Esc Enferm USP. 2015 Feb;49:101-8. doi: 10.1590/S0080-623420150000700015. Portuguese. PMID: 26761699.
Copy Download .nbib Format: NLM
Vascular endothelial dysfunction and pharmacological treatment.

World journal of cardiology

Su JB.
PMID: 26635921
World J Cardiol. 2015 Nov 26;7(11):719-41. doi: 10.4330/wjc.v7.i11.719.

The endothelium exerts multiple actions involving regulation of vascular permeability and tone, coagulation and fibrinolysis, inflammatory and immunological reactions and cell growth. Alterations of one or more such actions may cause vascular endothelial dysfunction. Different risk factors such as...

Cite
Su JB. Vascular endothelial dysfunction and pharmacological treatment. World J Cardiol. 2015;7(11):719-41doi: 10.4330/wjc.v7.i11.719.
Su, J. B. (2015). Vascular endothelial dysfunction and pharmacological treatment. World journal of cardiology, 7(11), 719-41. https://doi.org/10.4330/wjc.v7.i11.719
Su, Jin Bo. "Vascular endothelial dysfunction and pharmacological treatment." World journal of cardiology vol. 7,11 (2015): 719-41. doi: https://doi.org/10.4330/wjc.v7.i11.719
Su JB. Vascular endothelial dysfunction and pharmacological treatment. World J Cardiol. 2015 Nov 26;7(11):719-41. doi: 10.4330/wjc.v7.i11.719. PMID: 26635921; PMCID: PMC4660468.
Copy Download .nbib Format: NLM
Drug induced gingival overgrowth: a rare case report.

Journal of clinical and diagnostic research : JCDR

Mathur S, Khatri RK, Mathur R, Srivastava R, Nag BP.
PMID: 25738096
J Clin Diagn Res. 2015 Jan;9(1):ZD31-3. doi: 10.7860/JCDR/2015/11384.5500. Epub 2015 Jan 01.

Gingival overgrowth is well documented side effect associated with three major classes of drugs viz, anticonvulsants, calcium channel blockers, and immunosuppressants. Despite our greater understanding of pathogenesis of Drug induced Gingival Overgrowth (DIGO), its treatment still remains a challenge...

Cite
Mathur S, Khatri RK, Mathur R, et al. Drug induced gingival overgrowth: a rare case report. J Clin Diagn Res. 2015;9(1):ZD31-3doi: 10.7860/JCDR/2015/11384.5500.
Mathur, S., Khatri, R. K., Mathur, R., Srivastava, R., & Nag, B. P. (2015). Drug induced gingival overgrowth: a rare case report. Journal of clinical and diagnostic research : JCDR, 9(1), ZD31-3. https://doi.org/10.7860/JCDR/2015/11384.5500
Mathur, Setu, et al. "Drug induced gingival overgrowth: a rare case report." Journal of clinical and diagnostic research : JCDR vol. 9,1 (2015): ZD31-3. doi: https://doi.org/10.7860/JCDR/2015/11384.5500
Mathur S, Khatri RK, Mathur R, Srivastava R, Nag BP. Drug induced gingival overgrowth: a rare case report. J Clin Diagn Res. 2015 Jan;9(1):ZD31-3. doi: 10.7860/JCDR/2015/11384.5500. Epub 2015 Jan 01. PMID: 25738096; PMCID: PMC4347187.
Copy Download .nbib Format: NLM
Hypertension in Children and Adolescents.

The Physician and sportsmedicine

Daniels SR, Loggie JM.
PMID: 27424643
Phys Sportsmed. 1992 Apr;20(4):96-110. doi: 10.1080/00913847.1992.11710276.

In brief For hypertensive children and adolescents who participate in sports, hygienic interventions may already be adequate-or may be unachievable. Yet, the decision to initiate pharmacotherapy is difficult. Physicians must weigh factors such as the presence of end-organ damage...

Cite
Daniels SR, Loggie JM. Hypertension in Children and Adolescents. Phys Sportsmed. 1992;20(4):96-110doi: 10.1080/00913847.1992.11710276.
Daniels, S. R., & Loggie, J. M. (1992). Hypertension in Children and Adolescents. The Physician and sportsmedicine, 20(4), 96-110. https://doi.org/10.1080/00913847.1992.11710276
Daniels, S R, and Loggie, J M. "Hypertension in Children and Adolescents." The Physician and sportsmedicine vol. 20,4 (1992): 96-110. doi: https://doi.org/10.1080/00913847.1992.11710276
Daniels SR, Loggie JM. Hypertension in Children and Adolescents. Phys Sportsmed. 1992 Apr;20(4):96-110. doi: 10.1080/00913847.1992.11710276. PMID: 27424643.
Copy Download .nbib Format: NLM
Injectable therapy for Peyronie's disease.

Translational andrology and urology

Chong W, Tan RB.
PMID: 27298778
Transl Androl Urol. 2016 Jun;5(3):310-7. doi: 10.21037/tau.2016.03.15.

Peyronie's disease is a disfiguring and psychologically devastating disease, which continues to pose a significant clinical conundrum to the attending doctor. Many forms of therapy have been trialled but results have been inconsistent at best. Non-surgical therapy revolves around...

Cite
Chong W, Tan RB. Injectable therapy for Peyronie's disease. Transl Androl Urol. 2016;5(3):310-7doi: 10.21037/tau.2016.03.15.
Chong, W., & Tan, R. B. (2016). Injectable therapy for Peyronie's disease. Translational andrology and urology, 5(3), 310-7. https://doi.org/10.21037/tau.2016.03.15
Chong, Weiliang, and Tan, Ronny Ban Wei. "Injectable therapy for Peyronie's disease." Translational andrology and urology vol. 5,3 (2016): 310-7. doi: https://doi.org/10.21037/tau.2016.03.15
Chong W, Tan RB. Injectable therapy for Peyronie's disease. Transl Androl Urol. 2016 Jun;5(3):310-7. doi: 10.21037/tau.2016.03.15. PMID: 27298778; PMCID: PMC4893510.
Copy Download .nbib Format: NLM
Correction to Structure-Activity Relationship, Drug Metabolism and Pharmacokinetics Properties Optimization, and in Vivo Studies of New Brain Penetrant Triple T-Type Calcium Channel Blockers.

Journal of medicinal chemistry

Siegrist R, Pozzi D, Jacob G, Torrisi C, Colas K, Braibant B, Mawet J, Pfeifer T, de Kanter R, Roch C, Kessler M, Moon R, Corminboeuf O, Bezençon O.
PMID: 28234473
J Med Chem. 2017 Mar 09;60(5):2163. doi: 10.1021/acs.jmedchem.7b00219. Epub 2017 Feb 24.

No abstract available.

Cite
Siegrist R, Pozzi D, Jacob G, et al. Correction to Structure-Activity Relationship, Drug Metabolism and Pharmacokinetics Properties Optimization, and in Vivo Studies of New Brain Penetrant Triple T-Type Calcium Channel Blockers. J Med Chem. 2017;60(5):2163doi: 10.1021/acs.jmedchem.7b00219.
Siegrist, R., Pozzi, D., Jacob, G., Torrisi, C., Colas, K., Braibant, B., Mawet, J., Pfeifer, T., de Kanter, R., Roch, C., Kessler, M., Moon, R., Corminboeuf, O., & Bezençon, O. (2017). Correction to Structure-Activity Relationship, Drug Metabolism and Pharmacokinetics Properties Optimization, and in Vivo Studies of New Brain Penetrant Triple T-Type Calcium Channel Blockers. Journal of medicinal chemistry, 60(5), 2163. https://doi.org/10.1021/acs.jmedchem.7b00219
Siegrist, Romain, et al. "Correction to Structure-Activity Relationship, Drug Metabolism and Pharmacokinetics Properties Optimization, and in Vivo Studies of New Brain Penetrant Triple T-Type Calcium Channel Blockers." Journal of medicinal chemistry vol. 60,5 (2017): 2163. doi: https://doi.org/10.1021/acs.jmedchem.7b00219
Siegrist R, Pozzi D, Jacob G, Torrisi C, Colas K, Braibant B, Mawet J, Pfeifer T, de Kanter R, Roch C, Kessler M, Moon R, Corminboeuf O, Bezençon O. Correction to Structure-Activity Relationship, Drug Metabolism and Pharmacokinetics Properties Optimization, and in Vivo Studies of New Brain Penetrant Triple T-Type Calcium Channel Blockers. J Med Chem. 2017 Mar 09;60(5):2163. doi: 10.1021/acs.jmedchem.7b00219. Epub 2017 Feb 24. PMID: 28234473.
Copy Download .nbib Format: NLM
Pharmacokinetic drug interactions with clopidogrel: updated review and risk management in combination therapy.

Therapeutics and clinical risk management

Wang ZY, Chen M, Zhu LL, Yu LS, Zeng S, Xiang MX, Zhou Q.
PMID: 25848291
Ther Clin Risk Manag. 2015 Mar 19;11:449-67. doi: 10.2147/TCRM.S80437. eCollection 2015.

BACKGROUND: Coprescribing of clopidogrel and other drugs is common. Available reviews have addressed the drug-drug interactions (DDIs) when clopidogrel is as an object drug, or focused on combination use of clopidogrel and a special class of drugs. Clinicians may...

Cite
Wang ZY, Chen M, Zhu LL, et al. Pharmacokinetic drug interactions with clopidogrel: updated review and risk management in combination therapy. Ther Clin Risk Manag. 2015;11:449-67doi: 10.2147/TCRM.S80437.
Wang, Z. Y., Chen, M., Zhu, L. L., Yu, L. S., Zeng, S., Xiang, M. X., & Zhou, Q. (2015). Pharmacokinetic drug interactions with clopidogrel: updated review and risk management in combination therapy. Therapeutics and clinical risk management, 11449-67. https://doi.org/10.2147/TCRM.S80437
Wang, Zhi-Yu, et al. "Pharmacokinetic drug interactions with clopidogrel: updated review and risk management in combination therapy." Therapeutics and clinical risk management vol. 11 (2015): 449-67. doi: https://doi.org/10.2147/TCRM.S80437
Wang ZY, Chen M, Zhu LL, Yu LS, Zeng S, Xiang MX, Zhou Q. Pharmacokinetic drug interactions with clopidogrel: updated review and risk management in combination therapy. Ther Clin Risk Manag. 2015 Mar 19;11:449-67. doi: 10.2147/TCRM.S80437. eCollection 2015. PMID: 25848291; PMCID: PMC4373598.
Copy Download .nbib Format: NLM
A Comparative Study on Clinical and Biochemical Parameters in Amlodipine and Cilnidipine Treated Hypertensive Patients.

Journal of clinical and diagnostic research : JCDR

Shetty K, Shetty R, Bairy L, Rao P, Kiran A, Shetty M, Deepak, Nayak V.
PMID: 28658794
J Clin Diagn Res. 2017 May;11(5):FC01-FC05. doi: 10.7860/JCDR/2017/23825.9763. Epub 2017 May 01.

INTRODUCTION: Hypertension is a major health issue worldwide. Calcium Channel Blockers (CCBs) are the most commonly used antihypertensive agents. CCBs act on voltage-dependent calcium channels and they were categorized into two subclasses, Dihydropyridine (DHP) and non-Dihydropyridine (non-DHP) derivative. Amlodipine...

Cite
Shetty K, Shetty R, Bairy L, et al. A Comparative Study on Clinical and Biochemical Parameters in Amlodipine and Cilnidipine Treated Hypertensive Patients. J Clin Diagn Res. 2017;11(5):FC01-FC05doi: 10.7860/JCDR/2017/23825.9763.
Shetty, K., Shetty, R., Bairy, L., Rao, P., Kiran, A., Shetty, M., Deepak, & Nayak, V. (2017). A Comparative Study on Clinical and Biochemical Parameters in Amlodipine and Cilnidipine Treated Hypertensive Patients. Journal of clinical and diagnostic research : JCDR, 11(5), FC01-FC05. https://doi.org/10.7860/JCDR/2017/23825.9763
Shetty, Kiran, et al. "A Comparative Study on Clinical and Biochemical Parameters in Amlodipine and Cilnidipine Treated Hypertensive Patients." Journal of clinical and diagnostic research : JCDR vol. 11,5 (2017): FC01-FC05. doi: https://doi.org/10.7860/JCDR/2017/23825.9763
Shetty K, Shetty R, Bairy L, Rao P, Kiran A, Shetty M, Deepak, Nayak V. A Comparative Study on Clinical and Biochemical Parameters in Amlodipine and Cilnidipine Treated Hypertensive Patients. J Clin Diagn Res. 2017 May;11(5):FC01-FC05. doi: 10.7860/JCDR/2017/23825.9763. Epub 2017 May 01. PMID: 28658794; PMCID: PMC5483696.
Copy Download .nbib Format: NLM
Outpatient Hypertension Control and Prescribing Habits for Hypertension in Taiwan.

Acta Cardiologica Sinica

Lin CS, Chu YH, Hung YJ, Lee DY, Chen CY.
PMID: 27122755
Acta Cardiol Sin. 2013 Nov;29(6):539-49.

BACKGROUND: Hypertension control is of the utmost importance for reducing cardiovascular risk. In Taiwan, the hypertension control rate of the general population is low (25%). We investigated the factors affecting outpatient hypertension control to determine whether the low control...

Cite
Lin CS, Chu YH, Hung YJ, et al. Outpatient Hypertension Control and Prescribing Habits for Hypertension in Taiwan. Acta Cardiol Sin. 2013;29(6):539-49
Lin, C. S., Chu, Y. H., Hung, Y. J., Lee, D. Y., & Chen, C. Y. (2013). Outpatient Hypertension Control and Prescribing Habits for Hypertension in Taiwan. Acta Cardiologica Sinica, 29(6), 539-49.
Lin, Chung-Sheng, et al. "Outpatient Hypertension Control and Prescribing Habits for Hypertension in Taiwan." Acta Cardiologica Sinica vol. 29,6 (2013): 539-49.
Lin CS, Chu YH, Hung YJ, Lee DY, Chen CY. Outpatient Hypertension Control and Prescribing Habits for Hypertension in Taiwan. Acta Cardiol Sin. 2013 Nov;29(6):539-49. PMID: 27122755; PMCID: PMC4805033.
Copy Download .nbib Format: NLM
Addition of a renin-angiotensin-aldosterone system inhibitor to a calcium channel blocker ameliorates arterial stiffness.

Clinical pharmacology : advances and applications

Kiuchi S, Hisatake S, Kawasaki M, Hirashima O, Kabuki T, Yamazaki J, Ikeda T.
PMID: 26487804
Clin Pharmacol. 2015 Oct 08;7:97-102. doi: 10.2147/CPAA.S81880. eCollection 2015.

BACKGROUND: The aim of controlling hypertension is to protect against arteriosclerosis. Calcium channel blockers (CCBs) and renin-angiotensin-aldosterone system (RAAS) inhibitors have been reported to have antihypertensive effects, but their effect on the progression of arteriosclerosis is not fully understood....

Cite
Kiuchi S, Hisatake S, Kawasaki M, et al. Addition of a renin-angiotensin-aldosterone system inhibitor to a calcium channel blocker ameliorates arterial stiffness. Clin Pharmacol. 2015;7:97-102doi: 10.2147/CPAA.S81880.
Kiuchi, S., Hisatake, S., Kawasaki, M., Hirashima, O., Kabuki, T., Yamazaki, J., & Ikeda, T. (2015). Addition of a renin-angiotensin-aldosterone system inhibitor to a calcium channel blocker ameliorates arterial stiffness. Clinical pharmacology : advances and applications, 797-102. https://doi.org/10.2147/CPAA.S81880
Kiuchi, Shunsuke, et al. "Addition of a renin-angiotensin-aldosterone system inhibitor to a calcium channel blocker ameliorates arterial stiffness." Clinical pharmacology : advances and applications vol. 7 (2015): 97-102. doi: https://doi.org/10.2147/CPAA.S81880
Kiuchi S, Hisatake S, Kawasaki M, Hirashima O, Kabuki T, Yamazaki J, Ikeda T. Addition of a renin-angiotensin-aldosterone system inhibitor to a calcium channel blocker ameliorates arterial stiffness. Clin Pharmacol. 2015 Oct 08;7:97-102. doi: 10.2147/CPAA.S81880. eCollection 2015. PMID: 26487804; PMCID: PMC4607055.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 934 entries